Founded in 2013, Ally Bridge Group is a private equity investment firm based in Hong Kong. The firm prefers to invest through means of buyouts, growth capital and venture capital investments. The firm prefers to invest in the healthcare and life sciences sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
00000000 000000000 | 06-Feb-2022 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 2 | 000000 000 |
00000000000 | 11-Jan-2022 | 00000 00000 | 00000 | Other Healthcare Technology Systems | Generating Revenue | |
000000000000 | 06-Dec-2021 | 0000 | 00000 | Drug Discovery | Generating Revenue | |
0000000 0000000000 | 06-Dec-2021 | 000000000000 | 00000 | Special Purpose Acquisition Company (SPAC) | Generating Revenue | |
Arbor Biotechnologies | 09-Nov-2021 | Later Stage VC | 00000 | Drug Discovery | Pre-Clinical Trials | 00000 00 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
00000000 | 02-Dec-2021 | 000000000000000000 | |
0000000 | 29-Oct-2021 | 000 | 000.00 |
000000000 | 08-Oct-2021 | 000 | 00000 |
00000 | 18-Aug-2021 | 000000000000000000 | 00.00 |
Genuity Science | 16-Aug-2021 | Merger/Acquisition | 00000 |
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Frank Yu | Co-Founder, Chief Investment Officer & Chief Executive Officer | 00 | 0 | 0 | Hong Kong, Hong Kong |
Charles Wong | Chief Financial Officer | Hong Kong, Hong Kong | |||
Daniel Johnson | Chief Financial Officer, Ally Bridge Group (NY) LLC | New York, NY | |||
Charles Chon | Managing Director & Partner | 0 | 0 | 0 | Hong Kong, Hong Kong |
Alan Chen | Partner, Head of Private Equity & Managing Director | Hong Kong, Hong Kong |